skip to content
Primary navigation


DrugAzasite® (azithromycin) ophthalmic solution, 1% [Inspire Pharmaceuticals]

August 2008

Therapeutic area - Ocular


AzaSite (azithromycin) is indicated for the treatment of bacterial conjunctivitis caused by susceptible isolates of the following microorganisms:

  • CDC coryneform group G*
  • Haemophilus influenzae
  • Staphylococcus aureus
  • Streptococcus mitis group
  • Streptococcus pneumoniae

*Efficacy for this organism was studied in fewer than 10 infections.


AzaSite is the first macrolide ophthalmic antibiotic for bacterial conjunctivitis. It is more effective than placebo (63% vs. 50%, AzaSite and placebo, respectively) under clinical trial conditions. It is not clear that this drug is any more effective than other therapies also used for bacterial conjunctivitis.


Patient has bacterial conjunctivitis and has had failure or intolerance to at least two generically available ophthalmic antibiotics.

For example:

Ciprofloxacin $3.45 per 5 mL bottle
Sulfacetamide sodium 10% op solution $4 per bottle
Polymyxin B sul-trimethoprim $4 per bottle


MHCP Provider Call Center 651-431-2700 or 800-366-5411

back to top